SCHEMBL8930320

SCHEMBL8930320

NC(=O)CCC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.69
EGFR P00533 5/20 0.66
NR4A1 P22736 1/20 0.64
NR4A2 P43354 1/20 0.64
NR4A3 Q92570 1/20 0.64
MAOB P27338 1/20 0.60
SRD5A2 P31213 1/20 0.59
PLA2G4B P0C869 1/20 0.56
ALDH1A1 P00352 2/20 0.56
MAPT P10636 2/20 0.56
GAA P10253 1/20 0.56
HTT P42858 1/20 0.56
RAB9A P51151 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
FFAR1 O14842 1/20 0.55
FFAR4 Q5NUL3 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
PTGS1 P23219 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL958582 0.88 EGFR (0.69) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL6283205 0.85 EGFR (0.70) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL6811506 0.84 EGFR (0.69) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL1557011 0.84 FFAR1 (0.71) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL4152328 0.83 EGFR (0.72) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL27517502 0.83 EGFR (0.68) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL19753722 0.83 EGFR (0.64) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL2013554 0.83 PARP10 (0.71) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL23782481 0.82 EGFR (0.67) PARP10EGFRNR4A1NR4A2NR4A3
SCHEMBL119689 0.82 PARP10 (1.00) PARP10NR4A1NR4A2NR4A3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997028161-A1 NOVEL PYRROLO[2,3-D]PYRIMIDINES AND THEIR USE AS TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 1997-08-07 WO disclosed